Header Logo

Connection

DONNA MUZNY to Trastuzumab

Back to Details
This is a "connection" page, showing publications DONNA MUZNY has written about Trastuzumab.
DONNA MUZNY
Connection Strength
0.056
Trastuzumab
  1. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.